Pharmacogenomic adaptation of antiretroviral therapy: overcoming the failure of lopinavir in an African infant with CYP2D6 ultrarapid metabolism
- 20 November 2009
- journal article
- letter
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 66 (1), 107-108
- https://doi.org/10.1007/s00228-009-0753-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Empfehlungen zur antiretroviralen Therapie bei HIV-infizierten KindernMonatsschrift Kinderheilkunde, 2006
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversityThe Pharmacogenomics Journal, 2004
- CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosagesActa Psychiatrica Scandinavica, 2001
- Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.1999
- Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.1996